SCHEMBL24011597

SCHEMBL24011597

CN(C(=O)CCCCCNC(=O)NCc1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPIB P23284 1/20 0.55
▸ HDAC1 Q13547 5/20 0.54
▸ HDAC2 Q92769 5/20 0.54
▸ HDAC10 Q969S8 5/20 0.54
▸ HDAC8 Q9BY41 5/20 0.54
▸ HDAC6 Q9UBN7 5/20 0.54
▸ HDAC3 O15379 4/20 0.54
▸ HDAC4 P56524 4/20 0.54
▸ HDAC7 Q8WUI4 4/20 0.54
▸ HDAC11 Q96DB2 4/20 0.54
▸ HDAC9 Q9UKV0 4/20 0.54
▸ HDAC5 Q9UQL6 4/20 0.54
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ TP53 P04637 1/20 0.50
▸ EPHX2 P34913 1/20 0.47
▸ DRD4 P21917 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.45
▸ HPGD P15428 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24011406 0.89 HDAC1 (0.52) PPIBHDAC1HDAC2HDAC10HDAC8
SCHEMBL24011407 0.88 HDAC1 (0.49) PPIBHDAC1HDAC2HDAC10HDAC8
SCHEMBL30306652 0.88 HDAC1 (0.49) PPIBHDAC1HDAC2HDAC10HDAC8
SCHEMBL24011594 0.87 FLT4 (0.55) PPIBHDAC1HDAC2HDAC10HDAC8
SCHEMBL30306644 0.87 FLT4 (0.55) PPIBHDAC1HDAC2HDAC10HDAC8
SCHEMBL24011408 0.86 HDAC1 (0.48) HDAC1HDAC2HDAC10HDAC8HDAC6
SCHEMBL24011601 0.85 KDM4E (0.55) HDAC1HDAC2HDAC10HDAC8HDAC6
SCHEMBL24011094 0.85 HDAC1 (0.47) HDAC1HDAC2HDAC10HDAC8HDAC6
SCHEMBL24011098 0.84 HDAC6 (0.47) HDAC1HDAC2HDAC10HDAC8HDAC6
SCHEMBL30306667 0.84 HDAC6 (0.47) HDAC1HDAC2HDAC10HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115843295-B NAMPT modulators 赛特凯恩蒂克公司 2025-04-15 — — CN disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
CN-115843295-A NAMPT modulators 赛特凯恩蒂克公司 2023-03-24 — — CN disclosed
WO-2021226276-A2 NAMPT MODULATORS CYTOKINETICS, INC. (US) 2021-11-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348369-A1 NAMPT MODULATORS NAMPT, NNT, NAPRT PPIB 2626/4885HDAC1 51/4885HDAC2 138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback